Literature DB >> 7060243

The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol.

J Kieval, E B Kirsten, K M Kessler, S M Mallon, R J Myerburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7060243     DOI: 10.1161/01.cir.65.4.653

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Calcium blockers for cardiac disease: therapeutic implications.

Authors:  A Dodek; J Ruedy
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

2.  Hemodynamic interactions of a new beta blocker, celiprolol, with nifedipine in angina pectoris.

Authors:  B Silke; S P Verma; S Guy
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

Review 3.  Anaesthetic implications of calcium channel blockers.

Authors:  L C Jenkins; P J Scoates
Journal:  Can Anaesth Soc J       Date:  1985-07

4.  Diltiazem treatment for the management of ischaemia in patients with poor left ventricular function: safety of long term administration.

Authors:  M J Zema; S Perlmutter; S Mankes; C Nikitopoulos
Journal:  Br Heart J       Date:  1987-11

Review 5.  Calcium channel antagonists. Part IV: Side effects and contraindications drug interactions and combinations.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

6.  Cardiovascular collapse after verapamil in supraventricular tachycardia.

Authors:  C R Kirk; J L Gibbs; R Thomas; R Radley-Smith; S A Qureshi
Journal:  Arch Dis Child       Date:  1987-12       Impact factor: 3.791

7.  Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy.

Authors:  J C McGourty; J H Silas; S A Solomon
Journal:  Postgrad Med J       Date:  1985-03       Impact factor: 2.401

Review 8.  The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.

Authors:  A L Soward; G L Vanhaleweyk; P W Serruys
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

9.  Safety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial Fibrillation.

Authors:  Mohamad Badr Jandali
Journal:  Clin Drug Investig       Date:  2018-06       Impact factor: 2.859

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.